Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

plain language summary

What do we already know?

More than a third of rectal cancers are diagnosed in people aged 75 and over. The treatment of older patients is controversial. Older patients are less likely to receive surgery, radiotherapy and chemotherapy than younger patients. This may partly explain why England has a worse survival rate than some other European countries. However, some studies have suggested older patients have worse treatment outcomes than younger patients and so reduced treatment rates in this group are acceptable. The challenge is to neither over treat nor under treat older rectal cancer patients.

What did we do in our study?

This study used routinely collected English healthcare data to examine the use of different treatments for rectal cancer and their associated outcomes. It also assessed how treatment and outcome varied across the English NHS.

What did we find?

The results confirmed that older people were less likely to receive treatment aimed at curing them of rectal cancer. However, those older people who received such treatment had similar outcomes to younger patients. The study suggests that these treatments should be offered to patients of all ages if they are fit enough to receive them. It might be argued that a lower proportion of older people received these treatments because older patients are more likely to have other healthcare conditions and experience complications. The study did find some evidence to support this. However, the study found major differences between hospital Trusts which could not be accounted for by differences in patient characteristics.

Project Outputs